QIAGEN N.V. to release results for Q4 2023 and hold webcast
11 Janeiro 2024 - 9:53AM
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced
plans to release results for the fourth quarter and full year 2023.
Press release date/time: Tuesday, February 6, shortly after
22:05 Frankfurt time / 21:05 London time /
16:05 New York time.
Conference call date/time: Wednesday, February 7,
at 15:00 Frankfurt time / 14:00 London time / 09:00
New York time.
Three options for joining the conference call
- Register for call
back connection - Click here: Connect me
Service is available 15 minutes before the call starts
- Dial-in by
phone
U.S.: +1 646 828 8193UK: +44 (0)330 165 3655GER: +49 (0)69 6610
2492Conference ID: 2206067To avoid waiting time, please join
the event conference 5-10 minutes prior to the start
time.
- Access the audio
webcast - Click here: Access Webcast
A conference call replay will be available by using the
following
link:https://event.webcasts.com/starthere.jsp?ei=1643464&tp_key=a2e231b651
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample toInsight solutions that enable customers
to gain valuable molecular insights from samples containing the
building blocks of life. Our sample technologies isolate and
process DNA, RNA and proteins from blood, tissue and other
materials. Assay technologies make these biomolecules visible and
ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights.
Automation solutions tie these together in seamless and
cost-effective workflows. QIAGEN provides solutions to more than
500,000 customers around the world in Molecular Diagnostics (human
healthcare) and Life Sciences (academia, pharma R&D and
industrial applications, primarily forensics).As of
September 30, 2023, QIAGEN employed more than 6,000 people in
over 35 locations worldwide. Further information can be
found at http://www.qiagen.com.
source: QIAGEN N.V. category: Financial
John Gilardi
QIAGEN GmbH
+49 2103 29 11711
IR@qiagen.com
Phoebe Loh
QIAGEN N.V.
+49 2103 29 11457
IR@qiagen.com
Alexandra König
QIAGEN N.V.
+49 2103 29 11709
IR@qiagen.com
Qiagen NV (NYSE:QGEN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Qiagen NV (NYSE:QGEN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
